Form 4: Aethlon Medical Director Forfeits Shares for Tax

Aethlon Medical Director Chetan Shah forfeited 1,786 common shares to cover tax withholdings upon the conversion of restricted stock units.

Summary

• Chetan Shah, a Director of AETHLON MEDICAL INC, forfeited 1,786 shares of common stock.
• This forfeiture occurred on September 30, 2025, to cover tax withholdings related to the conversion of 4,465 vested and outstanding restricted stock units (RSUs).
• The shares were forfeited at a market price of $0.749 per share.
• Following this transaction, Chetan Shah beneficially owns 22,672 shares of Aethlon Medical common stock directly.
• The restricted stock units were part of a grant previously reported in a Form 4 filed on April 25, 2025.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary event for tax withholding on equity compensation, which is neutral in terms of company performance or insider sentiment.

Future Outlook

NA

Industry Context

This transaction is a routine event in executive compensation, where shares are withheld or forfeited to cover tax obligations upon the vesting and conversion of equity awards like restricted stock units. It reflects a standard practice across industries for managing equity-based compensation.

Stakeholder Impact

• The impact on shareholders is minimal as this is a routine, non-discretionary transaction for tax purposes, not indicative of a change in company fundamentals or insider sentiment regarding the stock's value.

Key Dates

Keywords

Aethlon Medical, AEMD, Chetan Shah, Form 4, Insider Transaction, Share Forfeiture, Restricted Stock Units, Tax Withholding, Director